Posters

Profiling non-medical use of tapentadol products among recreational drug abusers

Abuse and route of administration prevalence for tapentadol products within the NAVIPPRO® ASI-MV® surveillance system

A Cross-Sectional Analysis of Economic, Medical, and Legal Outcomes of Adults in Substance Abuse Treatment centers with Possible or Probable Schizophrenia

Recent Study: Progression of non-medical use of hydrocodone combination products: results from an Internet survey of recreational drug users

Patterns of abuse of hydrocodone combination products: Results from an Internet survey of recreational drug users

The changing abuse ecology: implications for evaluating the abuse pattern of extended-release oxymorphone and abuse-deterrent opioid formulations

Comparing abuse of extended-release versus immediate-release opioid analgesics adjusted for number of prescriptions and morphine-equivalent dose

Evaluation of an ADF product’s route of administration profile

Abuse of Reformulated OPANA® ER: early findings from NAVIPPRO® data

Change in prescription opioid abuse after introduction of an abuse deterrent formulation

Differences in rates of abuse and routes of administration for original and reformulated extended-release oxycodone among individuals assessed for substance abuse

Effects of reformulated OxyContin® among patients assessed for substance abuse treatment in the NAVIPPRO sentinel surveillance network